Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
DRMA
$0.76
+0.28%
DRMA
· Dermata Therapeutics, Inc.
$0.76
+0.00 (+0.28%)
At close · Nov 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because of historical and expected operating losses and net operating cash flow deficits, there is substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the financial statements, which is not alleviated by management's plans.”View the 10-Q filed Aug 11, 2026
Market Cap
$3.07M
Shares
4.02M
Volume · Nov 6
60.22K
Avg daily vol (3M)
3.39M
All webcasts
Earnings call · FY2021 Q3
Dermata Therapeutics, Inc. (DRMA) Q3 2021 Earnings Call
Net income
-$1.71M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 15, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 15, 2021 · complete as-filed document